Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03738891 · ClinicalTrials.gov registry record · NA
CoolSculpting and EMS for the Abdomen
A NA study of Body Fat Disorder, sponsored by Zeltiq Aesthetics.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 4
- Study locations
NCT03738891: Completed NA study of Body Fat Disorder, sponsored by Zeltiq Aesthetics.
NCT03738891 is a NA study of Body Fat Disorder that has completed, run by Zeltiq Aesthetics. The registered enrollment target is 50 participants, above the 32-participant average among 3 other Body Fat Disorder trials with a reported enrollment target (56% higher). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03738891, a NA study of Body Fat Disorder, has completed, sponsored by Zeltiq Aesthetics.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 4
- Study locations
Study Summary
Evaluate the use of Electromagnetic Muscle Stimulation as an adjunctive treatment to CoolSculpting.
Primary Outcome
The number of UADEs occurring during the study will be tabulated.
Conditions Studied
Interventions
- DEVICE Zeltiq CoolSculpting System alone
- DEVICE Electromagnetic Muscle Stimulation alone
- DEVICE EMS followed by CoolSculping
- DEVICE CoolSculpting followed by EMS
Study Locations (4)
California
- Marina Plastic Surgery - Marina del Rey
- Innovation Research Center - Pleasanton
- Laser & Skin Surgery Center of Northern California - Sacramento
North Carolina
- Aesthetic Solutions, P.A. - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-11-07 |
| Est. Completion | 2019-09-09 |
| Phase | NA |
What the finished NCT03738891 record still lists
NCT03738891 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, above the 32-participant average among 3 other Body Fat Disorder trials with a reported enrollment target (56% higher).
The record links to 1 condition, with Body Fat Disorder appearing as the primary indexed condition, and to 4 interventions - of which Zeltiq CoolSculpting System alone is the first listed.
NCT03738891 reports a single indexed study location in California, North Carolina.
Frequently Asked Questions
What is clinical trial NCT03738891 about?
NCT03738891 is a clinical study titled "CoolSculpting and EMS for the Abdomen". Evaluate the use of Electromagnetic Muscle Stimulation as an adjunctive treatment to CoolSculpting.
What is the current status of trial NCT03738891?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2018-11-07. Estimated completion is 2019-09-09.
What conditions does trial NCT03738891 study?
This clinical trial studies the following conditions: Body Fat Disorder.
What interventions are being tested in trial NCT03738891?
The interventions under investigation include: Zeltiq CoolSculpting System alone (DEVICE), Electromagnetic Muscle Stimulation alone (DEVICE), EMS followed by CoolSculping (DEVICE), CoolSculpting followed by EMS (DEVICE).
Who is sponsoring clinical trial NCT03738891?
This trial is sponsored by Zeltiq Aesthetics, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03738891 being conducted?
This trial has 4 study locations across California, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Body Fat Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI